Celecoxib for Stage III Colon Cancer

JAMA. 2021 Apr 6;325(13):1257-1258. doi: 10.1001/jama.2021.2651.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Celecoxib / therapeutic use
  • Colonic Neoplasms* / drug therapy
  • Disease-Free Survival
  • Humans
  • Reference Standards
  • Sulfonamides / therapeutic use

Substances

  • Sulfonamides
  • Celecoxib